Search hospitals > New Mexico > Albuquerque
Lovelace Medical Center-Saint Joseph Square
Claim this profileAlbuquerque, New Mexico 87102
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
101 reported clinical trials
14 medical researchers
Summary
Lovelace Medical Center-Saint Joseph Square is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Lovelace Medical Center-Saint Joseph Square is involved with conducting 101 clinical trials across 268 conditions. There are 14 research doctors associated with this hospital, such as Atul Kumar, Ursa A. Brown-Glaberman, Carolyn Y. Muller, and Neda Hashemi Sadraei.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Atul KumarUniversity of New Mexico Cancer Center4 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
38 drugs studied
Ursa A. Brown-GlabermanUniversity of New Mexico Cancer Center4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
18 reported clinical trials
42 drugs studied
Carolyn Y. MullerUniversity of New Mexico Cancer Center1 year of reported clinical research
Studies Cancer
Studies Endometrial Cancer
19 reported clinical trials
39 drugs studied
Neda Hashemi SadraeiUniversity of New Mexico Cancer Center4 years of reported clinical research
Studies Cancer
Studies Bladder Cancer
14 reported clinical trials
40 drugs studied
Clinical Trials running at Lovelace Medical Center-Saint Joseph Square
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Gallbladder Cancer
Prostate Cancer
Renal Cell Carcinoma
Small Cell Lung Cancer
Anal Cancer
Squamous Cell Carcinoma
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Single vs Multiple Dose Radiation
for Brain Metastases
This study is designed to see if we can lower the chance of side effects from radiation in patients with breast, kidney, small cell lung cancer, non-small cell lung cancer or melanoma that has spread to the brain and who are also being treated with immunotherapy, specifically immune checkpoint inhibitor (ICI) therapy. This study will compare the usual care treatment of single fraction stereotactic radiosurgery (SSRS) given on one day versus fractionated stereotactic radiosurgery (FSRS), which is a lower dose of radiation given over a few days to determine if FSRS is better or worse at reducing side effects than usual care treatment.
Recruiting1 award N/A
Chemotherapy Reduction After Surgery
for Breast Cancer
This study is evaluating whether a combination of drugs may help treat breast cancer.
Recruiting1 award Phase 227 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Lovelace Medical Center-Saint Joseph Square?
Lovelace Medical Center-Saint Joseph Square is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Lovelace Medical Center-Saint Joseph Square is involved with conducting 101 clinical trials across 268 conditions. There are 14 research doctors associated with this hospital, such as Atul Kumar, Ursa A. Brown-Glaberman, Carolyn Y. Muller, and Neda Hashemi Sadraei.